Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0FI5C
|
||||
| Former ID |
DCL000558
|
||||
| Drug Name |
MEDI-528
|
||||
| Drug Type |
Monoclonal antibody
|
||||
| Company |
MedImmune
|
||||
| Target and Pathway | |||||
| Target(s) | Interleukin-9 | Target Info | Inhibitor | [550288] | |
| NetPath Pathway | TCR Signaling Pathway | ||||
| IL2 Signaling Pathway | |||||
| PANTHER Pathway | Interleukin signaling pathway | ||||
| WikiPathways | TCR Signaling Pathway | ||||
| IL-9 Signaling Pathway | |||||
| References | |||||
| Ref 522773 | ClinicalTrials.gov (NCT00968669) A Study to Evaluate the Effectiveness and Safety of MEDI-528 in Adults. U.S. National Institutes of Health. | ||||
| Ref 889340 | ClinicalTrials.gov (NCT00394654) A Study to Evaluate the Efficacy of MEDI-528 on Late Asthmatic Response With Atopic Asthma | ||||
| Ref 889344 | ClinicalTrials.gov (NCT00483041) A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528 | ||||
| Ref 889345 | ClinicalTrials.gov (NCT00507130) A Study to Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multiple Doses to Adults With Mild Persistent Asthma | ||||
| Ref 889351 | ClinicalTrials.gov (NCT00590720) A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With Asthma | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.